mRNA-4157,Pembrolizumab
Moderna,Merck
['melanoma']
tomorrow at #aacr23, 's dr. jeffrey weber will present results of a phase 2 trial testing an mrna cancer vaccine paired with an immunotherapy to treat melanoma. don't miss it at 12:45pm in chapin theater! see our full list of presenters: 
The latest clinical news and research from experts at @nyulangone. Ranked #2 Best Medical School and #3 Best Hospital in the nation by U.S. News & World Report.